Australian (ASX) Stock Market Forum

TDL - TBG Diagnostics (1 Viewer)

Joined
Nov 1, 2006
Posts
372
Reactions
13
Having hovered around $2.50-$3 for most of the last year, PGL appears to now be on a nice, gentle upward trend, sitting at about $3.50 today. I'm surprised I've not seen any other mention of them here.
 
Joined
Nov 1, 2006
Posts
372
Reactions
13
Re: PGL - Progen Industries

An announcement of substantial holding has been submitted by SAC Capital, a massive US/Antigua investment fund. They've accumulated 6.9% of PGL over the past few months, buying on both the ASX and NASDAQ. That's sure to push things upwards.
 
Joined
Nov 11, 2006
Posts
4
Reactions
0
Re: PGL - Progen Industries

I have heard the trials are looking to start for their bio product and all signs point to this being a $20 stock in 12 months.

I was given the tip at $2.75 and bought in at $3.25.
 
Joined
Nov 1, 2006
Posts
372
Reactions
13
Re: PGL - Progen Industries

thecountof said:
I have heard the trials are looking to start for their bio product and all signs point to this being a $20 stock in 12 months.

Might not take that long!

PGLA has traded as high as US$8.74 on the NASDAQ today, currently US$7.73. I wonder how high it'll open today on our market?
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

Capital raising for PGL has seen a sharp down turn in price...

Anyone buying at the moment? The biotech daily boardroom radio person says they are a bargain at current prices.

He also said the same thing about AVX early on.

PGL could be the blue chipper of the biotechs....
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

PGL looks like it could be up 6% in the US.

Interesting one to watch at current prices.

Long term the brokers are giving it good wraps I have read but its still 4 years away.
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

What has happened to the market depth on this one?
There's hardly any buyers at all!


Its looking very thin all round.
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

Industry news implies changes to commercialisation strategies highly relevant to
PGL

We attended the annual BIO conference held in Boston MA USA last week. More than
20,000 industry professionals attended this year’s international convention with
presentations by a panel of experts from the industry including some of the finest thoughtleaders,
CEOs and other top executives. Three of the numerous presentations we attended
were highly relevant to PGL and we remain confident the company is on the right track to
commercialising its lead drug, PI-88.

Global biotech partnering trends indicate PGL retaining maximum possible value of
PI-88

The forecast for 2007-08 for international biotech deals points towards either very earlystage
deals or co-development at the later stage of development. This trend has largely
occurred because smaller biotechs are retaining significant control over the development of
their drug as well as much of the value. PGL is a clear case in point here and it seems that
its international peers are following the same path. Consequently, pharma companies have
been forced to become more flexible in their negotiations.

Adopting new and innovative clinical trial designs to speed up development
There is a trend towards creating new trial designs and clinical development programs that
will accelerate clinical trials, improve the probability of a drug’s success, reduce costs and
increase safety for patients. We believe PGL may consider adopting a new approach
involving the drug:placebo ration which would further accelerate the development of PI-88.
Buy 2 rating maintained based on $14.64 probability-weighted valuation

Whilst we remain disappointed with the heavy discount placed on the issue price in the
recent $74m capital raising, we maintain our Buy 2 rating. The various presentations we
attended at the recent BIO conference all point to PGL behaving like a successful global
biotech company. Our DCF probability-weighted valuation remains unchanged at $14.64.
We remain confident that this valuation gap will narrow over the next 6-12 months as PGL
embarks on the final stage of its commercialisation of PI-88.

INVESTMENT DATA
Share Price $5.86
Issued Capital
Ordinary Shares 59.3m
Options 0.6m
Fully Diluted 59.9m
Market Capitalisation $351.0m
52 Week Low/High $2.52 / $9.49
Valuation $14.64
Top 20 shareholders as at 30 June 2006 own
63% of total shares on issue
Year end Jun 06a 07f 08f 09f
Revenue $m 1.7 0.9 0.0 0.0
EBITDA $m -8.7 -16.9 -43.9 -38.2
NPAT $m -7.6 -16.8 -39.5 -35.8
EPS (adj) ¢ -18.8 -38.4 -90.7 -82.0
EPS growth % na na na na
PER x na na na na
Data is normalised and fully diluted.
Progen Pharmaceuticals (PGL) Buy 2
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

Anyone else positive on PGL future?
Is it the next blue chip biotech?

The good thing about biotechs is that they tend to be avoided by most, so good value can be found.

I believe there is still good value in PGL along with Avexa.
 

Joe Blow

Administrator
Staff member
Joined
May 28, 2004
Posts
10,038
Reactions
2,798
Re: PGL - Progen Industries

Industry news implies changes to commercialisation strategies highly relevant to
PGL

We attended the annual BIO conference held in Boston MA USA last week. More than
20,000 industry professionals attended this year’s international convention with
presentations by a panel of experts from the industry including some of the finest thoughtleaders,
CEOs and other top executives. Three of the numerous presentations we attended
were highly relevant to PGL and we remain confident the company is on the right track to
commercialising its lead drug, PI-88.

Global biotech partnering trends indicate PGL retaining maximum possible value of
PI-88

The forecast for 2007-08 for international biotech deals points towards either very earlystage
deals or co-development at the later stage of development. This trend has largely
occurred because smaller biotechs are retaining significant control over the development of
their drug as well as much of the value. PGL is a clear case in point here and it seems that
its international peers are following the same path. Consequently, pharma companies have
been forced to become more flexible in their negotiations.

Adopting new and innovative clinical trial designs to speed up development
There is a trend towards creating new trial designs and clinical development programs that
will accelerate clinical trials, improve the probability of a drug’s success, reduce costs and
increase safety for patients. We believe PGL may consider adopting a new approach
involving the drug:placebo ration which would further accelerate the development of PI-88.
Buy 2 rating maintained based on $14.64 probability-weighted valuation

Whilst we remain disappointed with the heavy discount placed on the issue price in the
recent $74m capital raising, we maintain our Buy 2 rating. The various presentations we
attended at the recent BIO conference all point to PGL behaving like a successful global
biotech company. Our DCF probability-weighted valuation remains unchanged at $14.64.
We remain confident that this valuation gap will narrow over the next 6-12 months as PGL
embarks on the final stage of its commercialisation of PI-88.

INVESTMENT DATA
Share Price $5.86
Issued Capital
Ordinary Shares 59.3m
Options 0.6m
Fully Diluted 59.9m
Market Capitalisation $351.0m
52 Week Low/High $2.52 / $9.49
Valuation $14.64
Top 20 shareholders as at 30 June 2006 own
63% of total shares on issue
Year end Jun 06a 07f 08f 09f
Revenue $m 1.7 0.9 0.0 0.0
EBITDA $m -8.7 -16.9 -43.9 -38.2
NPAT $m -7.6 -16.8 -39.5 -35.8
EPS (adj) ¢ -18.8 -38.4 -90.7 -82.0
EPS growth % na na na na
PER x na na na na
Data is normalised and fully diluted.
Progen Pharmaceuticals (PGL) Buy 2

Ken, where is this information from?

When quoting from other sources please provide either a link or mention specifically where the information came from.
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

Sorry the information is from bell potter report.

I believe the information to be a standard brokers report.
 
Joined
Nov 8, 2006
Posts
5
Reactions
0
Re: PGL - Progen Industries

Progen have announced they have been unsuccessful in the lung cancer trials but they have fast tracked FDA approval of the PI-88 for liver cancer. there has been a sharp downturn in price and major shareholders are pulling out. just wondering if anyone can shed some light on what is happening and what we may expect in the future?
 
Joined
May 2, 2007
Posts
3,498
Reactions
1,056
Re: PGL - Progen Industries

Dear Killer

I visited ASX site and could not see the announcement of its lung cancer failure test. Could you pls send a link ?
This share has been evaluated at $12 by BP and under constant buy. However the risk is always high.
I think there must be a bad news. The SP came down at $2.6 today- lowest in this year.
Sorry I do not have any tangible information to share.

Regards
 
Joined
May 2, 2007
Posts
3,498
Reactions
1,056
Re: PGL - Progen Industries

Seems no one is making any noise on PGL.
Recent report is Trial Phase 3 started with allowable by pass. Details are in company announcement. If successful - PGL will reach the roof and reverse is true as well.
For some reason when every other share fell on Thursday - PGL kept up with a marginal value though.

Any expert comments on its near future please ?

Regards

MIner
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

Now is the time I am afraid where the smart or stupids investors will make the decisions that in 3-5 years time will see them for richer or for poorer.

Whether they are in or out I think now is the time to decide.

@ $2.68 i think there is no looking back.

No hanging out for a bounce or a little positive run.

Your either in for the long haul now or your out for good.

IF PGL can get their drug to market bell potter is saying $14.00

According to my calculations thats 522% above current prices.


It is a stock that probly shouldnt take up a large percentage of a portfolio.

But if you have some profits that you want to swing into a high risk, high reward stock PGL has to be up there with one of the best on the market.


Phase 3 trials set to go. The question I ask is why are people exiting the stock when the finish line is so close.

I have read there is a competitor in the market but also read this competitor does no interfere with Progens business operations or market.
 
Joined
May 2, 2007
Posts
3,498
Reactions
1,056
Re: PGL - Progen Industries

Under valuation by Bell Potters - whose confidence shaken ?
Some facts : On 14 Sept 07 when PGL quoted at $3.58 this famous broker's competent research team mentioned this as a BUY with valuation $14.70.
On 5 Nov 07 the same competent team maintained the valuation as $14.70 when the share was quoted $2.87. Recommendation BUY
On 5 Dec 07 more competent people reviewed the previous research for all life science shares including PGL. It advised the valuation as $7.51 when quoted as $2.50. Speculative BUY.

Fair game of research : isn't it ? Head you loose and Tail I win . :banghead:
I have attached three reports for fun reading .

Regards

Disclaimer : this information is extracted from BP site and for dissemination only. I do have PGL share in my kitty as hot potato - can not swallo or vomit it . Use your own research and get professional advise based on your own circumstances.
 

Attachments

  • PGL 287 BPS 051107 REPORT.pdf
    231.5 KB · Views: 6
  • PGL 358 BPS 240907 REPORT.pdf
    256.7 KB · Views: 4
  • PGL 250 BPS 051207 REPORT.pdf
    267.3 KB · Views: 6

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

that is biotechs for you.

this is why biotechs are not part of any port folio. there are better assets out there offering less risk, and uncertainty.


all risks outlined in recent prospectus.

money to be made on PGL like with any stock, but as an investor in biotechs you know you have to wait you time. it may reach $14 but that could be in 3-5 years.


all depends if you want dividends, or consistant growth, it could all happen in a hurry for PGL.

1000% gains in 1 day, all possible in this sector.

thats the risks you take. risk reward.... what is it... please BLT, PSD, or any other biotech....
 
Joined
May 2, 2007
Posts
3,498
Reactions
1,056
Re: PGL - Progen Industries

Thanks Ken

Your points are well taken and they are good.

My point was not on the unpredictability of Bio tech shares but more on the about turn method of Bell Potter's analysis. I honestly fail to understand how a technical analysis based on facts, experience (mix of good and bad), access to a huge behind the scene intelligence, software, fully employed technical people the researches get 180 deg opposite.

As a miner I do not know what is the difference between a gambler in a casino giving tips to win and so called stock analysts in reputed broking houses giving the same in the name of research, methodology, analysis bla bla.

Regards
 

Ken

Joined
Aug 22, 2005
Posts
1,198
Reactions
0
Re: PGL - Progen Industries

Too many variables to be giving price targets for my liking.

How can you value a stock with no .eps.

I agree totally.
 
Joined
Nov 1, 2006
Posts
372
Reactions
13
Re: PGL - Progen Industries

Have a look at what's happening now. Having hit a low of $1.26 a couple of weeks ago, they are now $2 and buyers about 10:1.
 

Users who are viewing this thread

Top